tomcat-users mailing list archives

Site index · List index
Message view « Date » · « Thread »
Top « Date » · « Thread »
From Jens Neu <jens....@biotronik.com>
Subject Re: TLS+SSLv3 but no SSLv2
Date Fri, 22 Jan 2010 17:51:03 GMT
Christopher,

maybe that was a bit premature, running with 
SSLCipher="-ALL:+HIGH:+MEDIUM:!SSLv2":

openssl s_client -ssl2 -connect server:8443
CONNECTED(00000003)

...

---
Ciphers common between both SSL endpoints:
RC4-MD5         EXP-RC4-MD5     RC2-CBC-MD5 
EXP-RC2-CBC-MD5 DES-CBC-MD5     DES-CBC3-MD5
---
SSL handshake has read 1135 bytes and written 236 bytes
---
New, SSLv2, Cipher is DES-CBC3-MD5
Server public key is 1024 bit
Compression: NONE
Expansion: NONE
SSL-Session:
    Protocol  : SSLv2
    Cipher    : DES-CBC3-MD5
    Session-ID: 21D7302FAF313F61DF24661249FCF7FD
    Session-ID-ctx: 
    Master-Key: 3CAC5F9B8889222FFF7E1106232BFE34FC7A2CBD078833E0
    Key-Arg   : 448CA2E3F880EF06
    Start Time: 1264182312
    Timeout   : 300 (sec)
    Verify return code: 18 (self signed certificate)
---

Jens Neu
Health Services Network Administration

Phone: +49 (0) 30 68905-2412
Mail: jens.neu@biotronik.de



www.biotronik.com

BIOTRONIK SE & Co. KG
Woermannkehre 1, 12359 Berlin, Germany
Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRA 6501

Vertreten durch ihre Komplementärin:
BIOTRONIK MT SE
Sitz der Gesellschaft: Berlin, Registergericht: Berlin HRB 118866 B
Vorsitzender des Verwaltungsrats: Dr. Max Schaldach
Geschäftsführende Direktoren: Christoph Böhmer, Dr. Werner Braun, Dr. 
Lothar Krings

BIOTRONIK - A global manufacturer of advanced Cardiac Rhythm Management 
systems and Vascular Intervention devices. Quality, innovation, and 
reliability define BIOTRONIK and our growing success. We are innovators of 
technologies like the first wireless remote monitoring system - Home 
Monitoring®, Closed Loop Stimulation and coveted lead solutions as well as 
state-of-the-art stents, balloons and guide wires for coronary and 
peripheral indications. We highly invest in the development of drug 
eluting devices and are leading the industry with our bioabsorbable metal 
stent program.

This e-mail and the information it contains including attachments are 
confidential and meant only for use by the intended recipient(s); 
disclosure or copying is strictly prohibited. If you are not addressed, 
but in the possession of this e-mail, please notify the sender immediately 
and delete the document.

Mime
  • Unnamed multipart/alternative (inline, None, 0 bytes)
View raw message